Arcus Biosciences RCUS Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's retained earnings?
- Arcus Biosciences (RCUS) reported retained earnings of -$1.61B in Q1 2026.
- How has Arcus Biosciences's retained earnings changed year-over-year?
- Arcus Biosciences's retained earnings decreased by 29.7% year-over-year, from -$1.24B to -$1.61B.
- What is the long-term trend for Arcus Biosciences's retained earnings?
- Over 5 years (2020 to 2025), Arcus Biosciences's retained earnings has grown at a 35.2% compound annual growth rate (CAGR), from -$328.18M to -$1.49B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.